Sunday, April 21, 2019

QxMD Adapts Scientific Papers into Interactive Clinical Decision Support Tools

BWW News Desk
April 15, 2019

a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttp3A2F2Fwwwqxmdcomampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorQxMDSoftwareIncampindex1ampmd5e67d18828bf4b9d3c955d712d3987a78 relnofollowQxMD Software Inca a digital learning technology company that makes it easier for healthcare professionals HCPs to discover and apply the latest evidence for use in clinical practice today announced the availability of its newest pointofcare clinical tool a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttps3A2F2Fqxmdcom2Fcalculate2Fcalculator4992Finternationaliganpredictiontoolampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorInternationalIgANephropathyPredictionToolampindex2ampmd5b8435cbcce06183f304915dd7688f916 relnofollowInternational IgA Nephropathy Prediction Toola for a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttps3A2F2Fqxmdcom2Fcalculate2Fampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorCalculatebyQxMDampindex3ampmd5393d7fb6ed7e17526d2d53e18f86d476 relnofollowiCalculate by QxMDia mobile and web app users Coinciding with the JAMA Internal Medicine epublication of the paper a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttps3A2F2Fqxmdcom2Fr2F30980653ampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorEvaluatingaNewInternationalRiskPredictionToolinIgANephropathyampindex4ampmd57ba2f0b396c0fe85d42786b9f89bbd77 relnofollowEvaluating a New International RiskPrediction Tool in IgA Nephropathyaby Sean J Barbour MD MSc Rosanna Coppo MD FERA Hong Zhang MD PhD and others the Internal IgAN Prediction Tool becomes the fourth iCalculate by QxMDi tool to simultaneously publish with a peerreviewed paper or presentation since October 2018 The tool was also timed to go live at the moment Dr Barbour presented at the 2019 ISN World Congress of Nephrology in Melbourne pblockquotep idpullquotepblockquote p The QxMD publication tactic to include interactive calculators and tools at the time of publication is a winning proposition for all stakeholders and an important strategy to achieve rapid knowledge translation said QxMD CEO and Medical Director Daniel Schwartz MD FRCPC Authors and affiliated organizations benefit from augmented reach and impact for their research results Publishers benefit from additional publication brand visibility Most importantly patient populations benefit from healthcare providers ability to access resources that enhance early disease detection and diagnosis medical intervention and therapeutic treatment optimization p p The IgA Nephropathy Prediction Tool accurately predicts the longterm risk of worsening kidney function at the time of kidney biopsy diagnosis of IgA nephropathy measured as a 50 reduction in kidney function eGFR or the development of endstage kidney disease Developed by members of the International IgAN Network who analyzed data from a large number of adults with IgA nephropathy from around the world the IgAN Prediction Tool is most reliable in predicting the risk of kidney function decline up to 5 years after kidney biopsy p p IgA nephropathy is a highly variable condition and patients who have IgA nephropathy and the health professionals who support them have always wanted a more accurate way of predicting future renal function decline added Sean Barbour MD MSc FRCPC the studys lead author and assistant Professor Division of Nephrology Department of Medicine Faculty of Medicine UBC With our International IgAN Prediction Tool freely available on QxMD it can be incorporated intoregular care planning and pointofcare engagement forpatients with IgA nephropathy This is a major breakthrough and delivers on a key part of our knowledge translation strategy since the beginning of this project p p iCalculate by QxMDi is one of manyfree medical apps a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttp3A2F2Fqxmd2Freadampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorReadbyQxMD2Campindex5ampmd5878b12533737a0c0eb86d822855ae55d relnofollowRead by QxMDa a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttp3A2F2Flearnqxmdcom2Fampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorLearnbyQxMDampindex6ampmd59216db29a0e528da15a4202c350f98e9 relnofollowLearn by QxMDathat comprise the QxMD Pathways platform Together these apps provide millions of users with fast access to fulltext research continuing medical education CME and uptodate tools that drive disease recognition and therapy optimization Powered by a sophisticated personalization engine the platform aggregates PubMed feeds journal table of contents TOCs 450 diagnostic tools microlearning CME courses and more p p QxMD has a consistent history of publishing tools on iCalculate by QxMDi simultaneously at the time of publication in a peerreviewed paper or at a conference presentation The three most recent tools VQI SameDay Discharge October 2018 CLL Ball Score November 2018 and ROKS 2018 December 2018 were quickly used by thousands of global clinicians shortly after publication In addition to the iCalculate by iQxMD publication tactic QxMD also offers authors publishers and professionals in publications and medical communications the ability to transparently sponsor and disseminate research on the QxMD platform for greater publication reach and shareofvoice p p To learn more about QxMD please visit a referrerpolicyunsafeurl targetblank hrefhttpsctsbusinesswirecomctCTidsmartlinkampurlhttp3A2F2Fwwwqxmdcomampesheet51969565ampnewsitemid20190415005728amplanenUSampanchorwwwqxmdcomampindex7ampmd5491e468ff3fdd9364f5bdbdd335393a8 relnofollowwwwqxmdcoma p p bAbout QxMDbbrQxMD is a digital learning technology company that makes it easier for healthcare professionals HCPs to discover the latest evidence and decision support tools for use in clinical practice The companys HCP engagement platform comprises a library of trusted apps that provide millions of members with fast access to fulltext research continuing medical education CME and uptodate tools that drive disease recognition and therapy optimization Powered by a sophisticated personalization engine the platform aggregates PubMed feeds journal table of contents TOCs 450 diagnostic tools microCME courses amp more QxMD also serves other healthcare constituents such as hospitals libraries scholarly publishers and nearly 50 of the worlds top25 pharmaceutical companies p p p pimg referrerpolicyunsafeurl alt srchttpsctsbusinesswirecomctCTidbwnewsampsty20190415005728r1ampsidweb02ampdistronxamplangen stylewidth0height0span classbwct31415p

SOURCE: BUSINESS WIRE. ©2015 Business Wire

Comments

Registration Login
Registration Login
Registration Login
Registration